NWM
ABBV icon

Northcape Wealth Management’s AbbVie ABBV Stock Holding History

Northcape Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.46M Sell
11,322
-19
-0.2% -$4.21K 0.67% 50
2025
Q4 		$2.59M Sell
11,341
-153
-1% -$34.9K 0.73% 46
2025
Q3 		$2.66M Sell
11,494
-89
-0.8% -$18.1K 0.78% 42
2025
Q2 		$2.15M Sell
11,583
-5
-0% -$929 0.66% 47
2025
Q1 		$2.43M Buy
11,588
+1
+0% +$194 0.78% 39
2024
Q4 		$2.06M Sell
11,587
-1,095
-9% -$201K 0.67% 50
2024
Q3 		$2.5M Buy
12,682
+900
+8% +$168K 0.82% 45
2024
Q2 		$2.02M Buy
11,782
+1,253
+12% +$208K 0.73% 47
2024
Q1 		$1.92M Sell
10,529
-1,509
-13% -$260K 0.7% 50
2023
Q4 		$1.87M Sell
12,038
-191
-2% -$27.8K 0.68% 51
2023
Q3 		$1.82M Sell
12,229
-536
-4% -$78.7K 0.7% 49
2023
Q2 		$1.72M Sell
12,765
-341
-3% -$50K 0.62% 55
2023
Q1 		$2.09M Buy
+13,106
New +$2M 0.76% 45
2022
Q4 		– Sell
-14,290
Closed -$1.92M – 75
2022
Q3 		$1.92M Buy
14,290
+1,876
+15% +$269K 0.68% 54
2022
Q2 		$1.9M Sell
12,414
-1,580
-11% -$241K 0.73% 47
2022
Q1 		$2.27M Buy
13,994
+1,977
+16% +$287K 0.66% 50
2021
Q4 		$1.63M Buy
+12,017
New +$1.42M 0.55% 55

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northcape Wealth Management's ABBV Position: Q1 2026 in Review

Northcape Wealth Management reduced its AbbVie (ABBV) stake by 0.17% in Q1 2026, selling an estimated $4.21K and leaving 11,322 shares worth $2.46M. The position accounts for 0.67% of the portfolio, ranked #50.

Northcape Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 17 quarters since. The position peaked at $2.66M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Northcape Wealth Management held 11,322 shares of AbbVie worth $2.46M as of Q1 2026.
  • Northcape Wealth Management sold 19 AbbVie shares in Q1 2026, an estimated $4.21K.
  • AbbVie made up 0.67% of Northcape Wealth Management's portfolio in Q1 2026, its #50 holding.
  • Northcape Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 17 quarters since.
  • Northcape Wealth Management's AbbVie position peaked at $2.66M in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Northcape Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.